Skip to Main Content
Kallyope logo
Close Menu
    • About Us
    • Pipeline
    • Platform
    • Partnering
    • News & Resources
      • News
      • Resources
    • Careers
    Contact Us
  1. Home
  2. Resources
  3. In vitro Profile of Elismetrep (T6)

In vitro Profile of Elismetrep (T6)

Summary

A Potent and Highly Selective Blocker of the Migraine-Associated Channel TRPM8.

Program
Elismetrep
Date Posted
June 4, 2026
Content Type
Poster
Event
America Headache Society Annual Meeting

Content

T-06-In-vitro-Profile-of-Elismetrep.pdf

← Back to Resource Library

Kallyope logo
Kallyope Inc. | 430 East 29th Street, 10th Floor | New York, NY 10016
LinkedIn